US$ 22.09
glp 1 overdose Alarming rise in weight loss drug GLP-1 overdoses GLP-1 Overdose & Pharmaceutical Negligence
Description
Andreini C, Bertini I, Cavallaro G, Holliday GL, Thornton JM

The SELECT trial demonstrated semaglutide reduces major adverse cardiovascular events by 20% in non-diabetic patients, repositioning GLP-1 drugs as disease-modifying therapies
This is fundamentally different from how GLP-1 medications are dosed

Jaime Almandoz, medical director of UT Southwestern Medical Centers Weight Wellness Program, said in a news release

In her lab she had a talented research fellow, John Eng, with expertise in newer techniques for isolating peptides and determining their structures

A.DalbgeL
